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Is Intellectual Property a Hurdle for
Transferring Technology to Developing
Countries?
If so, How High of a Hurdle?
by CECILY ANNE O'REGAN*
I. Introduction
At the November 2003 Geneva Conference for the World
Intellectual Property Organization ("WIPO"), Professor Franqois
Dessemontet said:
When studying the impact of intellectual property on the
development of nations and the transfer of technology, the
famous motto 'the invisible hand' always comes to mind, as for
most success stories. There is no absolute proof that
intellectual property really increases the rate of economic
development, as there is no proof that the private ownership of
capital assets really led Japan and the Western world to their
economic supremacy over the former Socialist countries. There
can be no physical proof for the effect of law because laws are
as patents, copyrights and trademarks, intellectual realities.
The impact of any law is difficult to establish in a micro-
sociological, let alone in a macro-economic view!'
It is not surprising, therefore, that, depending on where you sit in
the world, intellectual property rights are viewed as either a blessing
* Cecily Anne O'Regan is a Patent Attorney with Wilson Sonsini Goodrich &
Rosati and an Adjunct Professor in the Masagung School of Management, University of
San Francisco. The author would like to thank Professors Charlotte Waelde, Andres
Guadamuz and Patricia Barclay of the University of Edinburgh for their inspiration and
teaching excellence. The author also thanks Patrick T. O'Regan Jr. for his encouragement.
The views expressed are solely those of the author.
1. Franqois Dessemontet, Professor, Schools of Law of Lausanne and Fribourg,
Address at the WIPO Geneva Conference (Nov. 17, 2003), http://www.wipo.int/
documents/en/meetings/2OO3/wipo wto/presentations/doc/dessemontet.doc.
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or a curse. On the one hand, intellectual property rights are the
mechanism which many believe drive the economies of developed
countries by spurring innovation and ideas . In fact, one of the first
things a venture capitalist in Silicon Valley will ask when deciding
whether to fund a start-up company is: what is the intellectual
property position?3 Consequently, the developed world views
intellectual property rights as the proverbial keys to the shackles that
bind less developed countries: if only they will believe and enact and
enforce legislation to protect intellectual property rights.4  "The
principal assumption is that patents induce invention and disclosure
that is socially beneficial, but which otherwise might not occur due to
the free-rider problem."'
From the other side of the fence, intellectual property rights are
viewed as a big stick that beats down the fragile economies in
developing countries. In effect, the intellectual property rights
appear as a glass ceiling that the developing countries cannot quite
break through, but through which they have a tantalizing view of
what might be: So close and yet so far.
Are intellectual property rights the hurdle to the transfer of
technology to developing countries? Or are there other, more subtle,
influences at work? Can other mechanisms be employed to
encourage the transfer of technology to developing countries? This
essay explores these complex questions.
II. Intellectual Property Rights
In order to understand the role intellectual property rights might
take in impeding the transfer of technology to developing countries, it
is important to understand what intellectual property rights
encompass. Intellectual property rights take many forms: These
2. PATRICK H. SULLIVAN, VALUE-DRIVEN INTELLECTUAL CAPITAL (John Wiley
& Sons 2000); DEPARTMENT FOR INTERNATIONAL DEVELOPMENT, THE UK
GOVERNMENT RESPONSE TO THE REPORT OF THE COMMISSION ON INTELLECTUAL
PROPERTY RIGHTS: INTEGRATING INTELLECTUAL PROPERTY RIGHTS AND
DEVELOPMENT POLICY (2002), http://www.iprcommission.org/papers/pdfs/govt-response
/govt-response.pdf.
3. How to Change the World, http://blog.guykawasaki.com2006/10/how to
change-t.html (Oct. 25, 2006).
4. Edmund Kitch, The Patent Policy of Developing Countries, 13 UCLA PAC. BASIN
L. J. 166 (1994).
5. Thomas F. Cotter, Market Fundamentalism and the TRIPS Agreement, 22
CARDOZO ARTS & ENT. L.J. 307 (2004-05).
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rights potentially protect everything from knowledge to identity.'
Patents protect useful ideas by giving inventors the right to exclude
others from making, using and selling their idea. Patent rights are a
quid pro quo exchange for the inventor placing information about the
invention into the public domain. Even in developed countries, some
would argue that a patent is not necessarily a fair exchange because
some ideas can be ascertained by exposure to the invention with very
little effort and without the need for a written description to place the
information into the public domain. Even worse, questionable
patents can ultimately increase the cost of innovation or provide a
deterrent for innovation.' Nonetheless, although patents have been in
and out of vogue over the years, patents are generally viewed as
having an overall positive impact on innovation.9
Copyrights have a rich tradition in western culture and serve to
protect original expressions by giving authors the right to control
their original works of authorship and derivate works made from
those works."'  "Copyright is about sustaining the conditions of
creativity that enable an individual to craft out of thin air ... a Sun
Also Rises, a Citizen Kane"" and the world is a richer place as a
result. Part of the bargain with society for this government grant is
that each of these rights is protected for only a limited time, and some
uses that are socially beneficial are still permitted. Patent has a
minimum term of 20 years as a result of the negotiations in GATT-
TRIPs,' while copyright has a minimum term of 50 years.13 Many
would argue, however, that the term of copyright far exceeds the
value of the work over the life of the copyright.
14
6. See HM TREASURY, GOWERS REVIEW OF INTELLECTUAL PROPERTY 13 (2006),
available at http://www.hm-treasury.gov.uk/d/pbr06-gowers-report-755.pdf.
7. See, e.g., European Patent Convention, Oct. 5, 1973, 1065 U.N.T.S. 199; U.S.
Patent Act, 35 U.S.C. § 1 (2000).
8. FEDERAL TRADE COMMISSION, To PROMOTE INNOVATION: THE PROPER
BALANCE OF COMPETITION AND PATENT LAW AND POLICY 1 (2003), http://www.ftc.gov/
os/2003/1 0/innovationpt.pdf.
9. Id. at 4.
10. See, e.g., Berne Convention for the Protection of Literary and Artistic Works,
Sept. 9, 1886, 828 U.N.T.S 221.
11. P. Goldstein, Copyright, 38 J. COPYRIGHT SOC'Y U.S.A. 109, 110 (1991).
12. Agreement on Trade-Related Aspects of Intellectual Property Rights Annex IC,
Part II, § 5, art. 33. Apr. 15, 1994, 33 J.L.M. 1197 (1994).
13. Id. at Annex 1C, Part II, § 1, art. 12.
14. Tobias Schonwetter, The Fallacy of Long Copyright Protection, ICOMMONS, Apr.
3, 2007, http://icommons.org/2007/04/03/the-fallacy-of-long-copyright-protection/.
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Additional intellectual property rights protect an enterprise's
distinctive identity by providing protection to marks used on
conjunction with goods or services under trademark law. In some
countries, the design of a product or ornamentation can also be
protected. Lastly, trade secret protection can be used to protect
business information that has value to an organization because it is
not generally known. A trade secret can encompass anything from
business contact lists to the formula for Coca Cola".
The objective of any intellectual property system is two fold:
knowledge dissemination and promotion of investment in
knowledge creation and business innovation. First, it must
promote the widespread dissemination of new knowledge by
encouraging rights-holders to place their ideas and inventions
on the market. Second, it must promote investments in
knowledge creation and business innovation by establishing
exclusive rights to use and sell newly developed technologies,
goods and services.i 5
These objectives are the hallmark of the common elements of
current intellectual property systems.
III. Technology Transfer Hurdles for Developing Countries
Intellectual property rights alone are not a hurdle for
transferring technology to developing countries. Several other factors
negatively impact a developing country's access to technology.
A. Cost
Even if strong intellectual property rights are available in a
country, as a practical matter the cost of the goods or services may be
prohibitive relative to the income of the people. This would hold true
in many sectors but is frequently illustrated in both the
pharmaceutical sector and the software sector. "[M]ost
observers ... have concluded that it will take much more than strong
patent rights to induce this type of research (i.e., research into
diseases that are endemic principally to the developing world)."1 In a
simple economic model, goods and services are sold at a single price
15. Maskus, Intellectual Property Rights and Economic Development, 32 CASE W.
RES. J. INT'L L. 471, 474 (2000).
16. Cotter, supra note 5, at 335.
17. Id.
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that is determined by the market." In real life, however, differential
pricing is more common. 9 The difficulty arises, however, when the
price differential becomes too great. Companies must constantly
balance the cost of goods in a particular market against the potential
backlash for the cost of goods in other markets. In the
pharmaceutical industry, product differentiation-e.g., achieved by
formulation changes-can be used to justify price differences, even if
only semantically. ° In the software sector, regionalization, which can
occur by making a product available in a local language, typically is
not sufficient to justify the cost differential or the backlash that would
be seen in the major markets." Regardless, companies cannot expect
to distribute goods at a price charged in major markets of developed
countries when the purchasing power of developing countries is ten to
twenty times lower.22
B. Infrastructure
An obvious obstacle to technology transfer to developing
countries is the lack of infrastructure in the form of technical skills
and institutional support.23 It is one thing to make technology
available, it is quite another to have the tools necessary to exploit the
technology. Furthermore, the "lack of governmental commitment to
technological growth through inadequate funding and favorable
policy has exacerbated the movement of skilled manpower from the
South to the North (brain drain syndrome). 24 Patents alone cannot
be blamed for poor access to technology. For example,
[p]oor countries' insufficient access to essential drugs has been
blamed on the absence of crucial international humanitarian
aide assistance in the area of health services ... Though many
of the African countries studied accord patent protection to
pharmaceuticals, only few patentees of the 15 antiretroviral
18. Kevin Outterson, Pharmaceutical Arbitrage: Balancing Access and Innovation in
International Prescription Drug Markets, 5 YALE J. HEALTH POL'Y L. & ETHICS 193, 203
(2005).
19. Id.
20. Id. at 207.
21. Catalin Cosovanu, Piracy, Price Discrimination, and Development: The Software
Sector in Eastern Europe and Other Emerging Markets, 31 AIPLA Q.J. 165, 216 (2003).
22. Id. at 194.
23. Remigius N. Nwabueze, What Can Genomics and Health Biotechnology Do for
Developing Countries?, 15 ALB. L.J. Sci. & TECH. 369, 389 (2004-05).
24. Id. at 390.
6 -OREGAN DEVELOPINGCOUNTRIES STLJ EDI' v2FINAL EDIT MAC&HAND (Do NOI DELETE)2/8/2009 7:47:32 AM
6 HASTINGS SCIENCE & TECHNOLOGY LAW JOURNAL [Vol. 1:1
treatments (used to treat AIDS) have actually patented their
products in Africa ... The result is that in some African
countries.., no patent protection was sought for any of the 15
antiretroviral treatments studied, yet there is still a serious
problem of access to antiretroviral drugs in those countries.2
Patents do not operate in a vacuum. The usefulness of patents is
dependent on their ability to provide protection in the market. A
company will not invest in a patent unless it is obtaining value for that
investment. Similarly, the per se absence of a patent will not prevent
an otherwise patentable invention from being available, as evidenced
by the access to retroviral drugs in Africa. Patents are typically
obtained where a manufacturer believes it can get coverage that will
exclude others from making, using or selling. In the case of Africa,
there is little infrastructure available from which a company needs to
protect itself from a competitor making a sophisticated medicament.
However, there is also no real economy into which drugs can be sold.
C. Heavy-handed Enforcement
In order to get foreign direct investment, a country must have
strong intellectual property rights enacted. Once those strong rights
are enacted, however, individuals who once made a living selling
counterfeit goods are displaced."6 "For instance, in Lebanon, shortly
after adopting a stronger IPR (intellectual property right) system,
piracy and counterfeiting activities decreased while unemployment
increased.,27  With these up-front costs to intellectual property
reform, it takes a leap of faith to believe that there will be a pay-off in
the end. Many developing countries may have a difficult time making
that leap.
D. Compulsory Licenses
Some would argue that the fact that the TRIPs agreement allows
compulsory licenses is an impediment to technology transfer to
developing countries.8 Although the rationale for compulsory
licenses is laudable (i.e., enabling a country to issue a compulsory
license at times of national emergency), it is not at all unlikely that
25. Id. at 401.
26. J. Homere, Intellectual Property Rights Can Help Stimulate the Economic
Development of Least Developed Countries, 27 COLUM. J. L. & ARTS 277, 290 (2003-04).
27. Id.
28. Cotter, supra note 5, at 308.
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the compulsory license provision would make a commercial
enterprise reticent to make its patented products available for fear
that a country would abuse its sovereign authority to issue
compulsory licenses.9 Another problem is that while parties to a
license are in the best position to determine the value of a license, a
governmental agency that institutes a compulsory license will be ill
equipped to fairly determine a compensation rate for the intellectual
property rights holder.3
Another drawback to compulsory licensing is the threat it would
create to pricing in the home country.' For example, if a large
pharmaceutical company had a compulsory license granted such that
it was required to sell a patented medication for $10 per 100 pills, and
that number of pills sold for $100 at home, in this age of nearly
instantaneous transmission of information, the consumers in the
home country would likely storm the gates and demand some price
adjustment in their market. Large companies cannot afford this kind
of pressure and bad press. As noted in an interview with Rene
Bonvanie, Oracle's Vice President for Marketing, it would be "better
[to] just give it away for free. This way you can at least get better
public relations for the company. 3 2 Most companies would probably
prefer the positive press of humanitarian efforts to the negative press
of price differentials.
IV. The Existence of Intellectual Property Rights Alone is an
Insufficient Incentive for Technology Development and
Transfer
Even in developed countries, the existence of intellectual
property rights is largely an insufficient incentive for technology
development. The reality is that, for example, "biotechnology R&D is
an expensive enterprise and only wealthy countries and corporations
can afford the necessary investment."" It is for this reason that,
notwithstanding the grant of intellectual property rights, governments
in developed countries have devised a series of incentives to
encourage research and development.
29. Alan 0. Sykes, TRIPs, Pharmaceuticals, Developing Countries, and the Doha
"Solution," 3 CHI. J. INT'L L. 47 (2002).
30. Cotter, supra note 5, at 324.
31. Id. at 338.
32. Cosovanu, supra note 21, at 216.
33. Nwabueze, supra note 23, at 388.
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A. Government Research
In most developed countries, it is estimated that 1 percent to 3
percent of a country's gross domestic product is spent funding
research. 4 Research can be funded either by private companies or by
the government. According to the National Science Foundation, in
1999 federal funding accounted for 22.5 percent of basic research
funding in the United States. In the U.S. following World War II, it
was widely believed that information developed as a result of federal
funding should remain in the public domain. 36 This belief did not
change until the 1980s.
Some would argue, however, that government funding is not a
requirement for economic growth and, in fact, is probably an
impediment. Professor Kealey argued that "[w]ithout government
funding of science, the United States overtook Britain around 1890 as
the richest country in the world." 37  While Professor Kealey's
provocative statement may be technically true, it is also true that the
United States was a large country with vast, largely untapped, natural
resources at the time and its success in overtaking Britain was likely
impacted by other influences, such as its large and inexpensive
immigrant work force, a societal tendency towards meritocracy, and
simply being in the right place at the right time. Were the U.S. faced
with today's two-gap theory, which "postulates that developing
countries are unable to create and maintain the technological growth
to promote economic development because they lack the necessary
capital," 38 the results may have been quite different. In fact, under
current conditions, developing countries face a frustrating cycle
where industrial imports often exceed agricultural exports, creating
an unending cycle of debt.3' This was not an economic reality faced
by the U.S. in the late 1800s.
34. See, R&D in Knowledge-Intensive Economies, http://www.nsf.gov/statistics/
seind08/c0/c0s3.htm.
35. Ronald L. Meeks, Federal Funding Supports Moderate Growth for Basic Research
in the 1990's, NATIONAL SCIENCE FOUNDATION, Dec. 31, 1998, http://www.nsf.gov/
statistics/databrf/sdb99319.htm.
36. David Hoffman, A Modest Proposal: Toward Improved Access to Biotechnology
Research Tools by Implementing a Broad Experimental Use Exception, 89 CORNELL L.
REV. 993 (2003).
37. Terence Kealey, End Government Science Funding, CATO INSTITUTE, Apr. 11,
1997, http://www.cato.org/dailys/4-11-97.html.
38. Homere, supra note 26, at 283.
39. Id.
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Furthermore, while federal funding might provide a good
foundation for research funds, it is also subject to the political whims
of elected officials. Research that might be promoted under one
political administration might be curtailed under another regime.
Take for instance, the current limitations on stem cell research in the
United States under the Bush administration's policies. It is not at all
inconceivable that those limitations would be lifted under another
politician's agenda. Many states in the U.S. have decided to fund
stem cell research on the state level to overcome the lack of federal
funding. 4° Even in Europe, there is a deep divide over the issue of
stem cell research funding, with the U.K. on the side of funding and
Germany opposed to funding.4'
Although there is evidence to suggest government funding has a
positive impact on research, there is also evidence to suggest that
government funding is not a requirement for innovation. For
example, University of Pennsylvania economist Edwin Mansfield has
observed a correlation between the amount of money a company
invested in pure science research and its overall productivity. 4 While
logically it would seem that investing in pure science would take
resources away from the corporate agenda and the bottom line,
thereby reducing productivity, Mansfield has found the opposite:
Investment in basic research had a positive overall impact on
productivity for a company.
Nonetheless, as a practical matter, governments are answerable
to their citizenry and subject to elections over longer periods of time.
It can be argued that governments are more willing to fund high-risk
research, provided that the research does not risk overly offending
the moral sensibilities of a large voting block, or to fund research that
is placed in the public domain to encourage derivative research. 3
Corporations, on the other hand, are generally intended to be for-
profit enterprises and are answerable to shareholders on a quarterly
40. California Gives Go-Ahead to Stem-Cell Research, MSNBC.COM, Nov. 3, 2004,
http://www.msnbc.msn.com/id/6384390/; Aaron Levine, The Rise of State-Sponsored Stem
Cell Research in the United States, THE NEW YORK ACADEMY OF SCIENCES,
http://region.princeton.edu/media/pub/pub-xtra_16.pdf.
41. EU to Fund Embryo Stem Cell Research, BBC NEWS, July. 24, 2006,
http://news.bbc.co.uk/2/hi/europe/5209106.stm.
42. Id.
43. Nwabueze, supra, note 23.
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basis.44  It is generally difficult for a corporation, particularly a
publicly traded corporation, to benevolently fund research that might
be beneficial in the long term unless it is likely to add to the bottom
line. As a result of this difficulty, in the United States the National
Institute of Standards and Technology has an Advanced Technology
Program that co-funds high-risk projects. 4' These high-risk projects
are also recognized as having the potential for high return.
B. The Bayh-Dole Act - Providing Incentives for Commercialization
by Putting Government Sponsored Research into Private Hands
Prior to 1980, federally funded research did not provide a clear
path of ownership of intellectual property rights which impeded any
attempt to commercialize the results of academic research and acted
as a disincentive to obtain grant funding for anything that might be
commercializable. With the passing of the Bayh-Dole Act in 1980,4
universities, faculty inventors, and companies could use federal funds
to engage in research and then transfer the results of their research to
create companies, thereby creating jobs. An important feature of the
Bayh-Dole Act was that it "created default ownership of patent rights
for universities and allowed for exclusive licensing., 41 It should be
noted, however, that the government retains limited march-in rights
(e.g., in the event the technology has value and is not commercialized
by the funded organization).4 1 Such march-in rights, however, are
rarely, if ever, exercised•.4  As a result of the Bayh-Dole Act,
university technology transfer offices were created and the
exploitation of government-funded research became a way for
universities to increase their coffers. According to the Association of
University Technology Managers (AUTM),
44. See, e.g., David L. Scott, WALL STREET WORDS: AN A TO Z GUIDE TO
INVESTMENT TERMS FOR TODAY'S INVESTOR (Houghton Mifflin Company 2003). An
exception to this general rule is Benetech, a non-profit formed to create new technology
solutions that serve humanity and empower people to improve their lives
(http://www.benetech.org).
45. Funding Opportunities National Institute of Standards and Technology,
http://www.nist.gov/public-affairs/grants.htm (last visited Nov. 18, 2008).
46. Bayh-Dole Act, 35 U.S.C. §§ 200-212 (2000).
47. Sara Boettiger & Alan Bennett, The Bayh-Dole Act: Implications for Developing
Countries, 46 IDEA 261, 261 (2006).
48. Bayh-Dole Act, 35 U.S.C. § 203 (2000 & Supp. 112002).
49. Boettiger & Bennett, supra note 47, at 276; Gregg S. Sharp, A Layman's Guide to
Intellectual Property in Defense Contracts, 33 PUB. CONT. L.J. 99, 118 (2003).
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data from 222 institutions in the US and Canada, show that
sponsored research expenditures rose by 16.6% in 2002,
compared to 2001, while US patent applications increased by
more than 13%. Licenses and options were up by more than
15%, while license-related income jumped by almost 12%.
University licensing activities and the Bayh-Dole Act is not
without its detractors. University technology transfer organizations
are measured by the amount of revenue generated which, like a for-
profit corporation, gives them incentive to turn research into a
revenue stream. 1 This incentive can undermine a university's charge
of representing the public trust by incentivizing the university to
pursue technologies that are likely to be patentable and/or
licensable. These incentives may also trickle down to faculty who
may be lured from the intellectual pursuits of fundamental research
toward more lucrative, industrially applicable research.53 Of concern
in the U.K. is that that the pressure to patent results may inhibit the
free exchange of ideas among colleagues. a
In a frightening statistic, less than 10 percent of health research
funding is directed to diseases that affect 90 percent of individuals
worldwide. s  For instance, "though pneumonia and diarrhea
(prevalent in developing countries) constitute "11% of the global
disease burden," only 0.2 percent of the global research budget was
spent in them in 1992."6 At the university level, this could at least in
50. Managing Intellectual Property, University Licensing on the Rise, MANAGING
INTELLECTUAL PROPERTY, Jan. 11, 2004, http://www.managingip.com/Article/1325974
/University-licensing-on-the-rise.html.
51. Boettiger & Bennett, supra note 47, at 263.
52. Id. at 264.
53. Id. at 266.
54. Keeping Science Open: The Effects of Intellectual Property Policy on the Conduct
of Science, THE ROYAL SOCIETY, Apr. 2003, http://royalsociety.org
/displaypagedoc.asp?id= 11403.
55. Steven Price et al., Helping Developing Countries Level the Playing Field,
Address to the Global Forum for Health Research 8' Mexico (Nov. 2004), available at
http://www.globalforumhealth.org/Forum8/Forum8-CDROM/OralPresentations/
Price%20S %20F8-644.doc.
56. Nwabueze, supra note 23, at 387, (citing COMMISSION ON HEALTH RESEARCH
FOR DEVELOPMENT, HEALTH RESEARCH: ESSENTIAL LINK TO EQUITY IN
DEVELOPMENT (1990), available at http://www.ksg.harvard.edu/sed/docs/k4dev/
chen healthres execsum _1990.pdf.
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part be the result of a lack of incentive to work on basic research or
research that cannot be translated into a potential income stream.
Another fallout from the Bayh-Dole Act is restricted access to
research tools."' Prior to the Bayh-Dole Act, methods and research
tools that were developed under federal grants were rarely patented.
These efforts were, instead, published in scientific literature and
placed into the public domain. 9 Academics followed the adage
"publish or perish," not "patent or perish." As a result, there were no
restrictions on the use of, or access to, these methods and tools, which
enabled further development. Currently, although a university may
develop a highly useful research tool that it licenses to industry, that
university will only generally retain a right to practice the invention
within its own institution. Consequently, other universities are
precluded from using the tool in their research without getting a
license from the commercial partner. The commercial partner, being
a for-profit enterprise, has no obligation to offer a license at terms
that would be beneficial to another non-profit university.
In spite of its imperfections and arguably unintended negative
consequences, the Bayh-Dole Act does, however, illustrate a
mechanism whereby government sponsored research can be used to
generate income and used to develop commercializable industry.
Notwithstanding the criticisms, the Bayh-Dole Act has had an overall
positive impact on research and economic development, at least in
developing countries.
C. Orphan Drugs - Fostering Development of Much-Needed Drugs
Through Incentives
Orphan drug acts, which are available in several developed
countries, present an interesting approach to providing incentive to
develop technology. Under an orphan drug act, a government can,
for example, provide a variety of incentives to companies who
perform research or spend resources developing drugs that otherwise
might not be commercially viable. In developed countries, orphan
drugs are typically categorized as drugs developed to treat diseases
that affect a relatively small percentage of a population. Incentives
can include tax benefits; granting additional rights, such as market
exclusivity; and subsidizing clinical trial research.
57. Nwabueze, supra note 23, at 392.
58. Boettiger & Bennett, supra note 47, at 278.
59. Hoffman, supra note 36, at 1005.
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In the United States, in 1983, Congress enacted the Orphan Drug
Act to provide incentive for researching drugs to treat diseases and
conditions that affect 200,000 people or fewer.") The European Union
has a similar incentive program administered by the Committee on
Orphan Medicinal Products of the European Medicines Agency.'
The European program is designed to provide incentives to develop
drugs for diseases with a prevalence of less than 5 per 10,000 in a
community, or for which "drug marketing would be unlikely to
generate sufficient returns to justify investment. ,62
Since the enactment of the Orphan Drug Act in the United
States, over 1100 different orphan drug designations have been
granted by the Office of Orphan Products Development ("OOPD")
and over 250 orphan drugs have received marketing authorization.
63
In contrast, the decade prior to 1983 saw fewer than ten such products
come to market. The poster child for orphan drugs is Amgen's
Epogen which had sales of $2.4 billion in 200314, but which might not
have been developed but for the Orphan Drug Act. Admittedly, the
profitability of Epogen makes the orphan drug moniker a bit of a
misnomer. The European Union has seen similar success with some
of the orphan drugs it has developed. In the European Union, from
April 2000 through June 2004, the European Commission had
granted 204 orphan drug designations.6
The inherent problem with the orphan drug programs is that the
programs are intended to provide subsidies to treat relatively rare
conditions and diseases which have low incidence in the population.
The rationale is that with low incidence, there is insufficient economic
incentive to develop a drug to treat the disease. However, nothing in
the orphan drug acts provides an incentive to develop drugs and
therapies to treat conditions which have high incidence in third world
populations but a low incidence in developed regions. Therefore, it is
60. Orphan Drug Act, 21 U.S.C. § 360ee (2007).
61. EMEA Human Medicines-Orphan Medicinal Products web site, http://www.
emea.europa.eu/htms/human/orphans/incentives.htm (last visited Nov. 18, 2008);
Commission Regulation 141/2000, 2000, O.J. (L18) 1.
62. STEPHEN SEGET, ORPHAN DRUGS TO 2008: UNDERSTANDING REGULATION
AND MARKET OPPORTUNITY IN EUTROPE (Urch Publishing 2005).
63. Orphan Drugs: Established by FDA to Expedite Patient Access to Medications,
60 AM. J. HEALTH-SYS. PHARM 339 (2003), available at http://www.medscape.com
/viewarticle/449551_6; see also, Seget, supra note 62.
64. Seget, supra note 62.
65. Id.
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not surprising that "out 'of the 1233 new drugs marketed between
1975 and 1999, only 13' were for diseases suffered in developing
countries.
,6
V. Technology Transfer Opportunities and Mechanism for
Developing Countries to Consider
A. Traditional Knowledge
Issues surrounding traditional knowledge present a unique
challenge to the transfer of intellectual property. Not surprisingly,
the view of developed countries toward the value of traditional
knowledge is quite different than the view of developing countries.67
For instance,
poor countries have been told to preserve their ... genetic
resources on the off-chance that at some future date something
is discovered which might prove useful to humanity... [They]
are also told that the right will not agree to compensate the
poor for their sacrifices. The poor are not asking for charity.
When the rich chopped down their own forests ... and scoured
the world for cheap resources, the poor said nothing... Now
the rich claim a right to regulate the development of poor
countries. And yet any suggestion that the rich compensate the
poor adequately is regarded as outrageous. As colonies, we
were exploited. Now, as independent nations, [they] are to be
equally exploited.
Traditional knowledge does have the potential to make a
valuable contribution toward innovation and can be used to promote
technology transfer. However, by virtue of the fact that members of a
particular culture have known traditional knowledge for an extended
period of time, it does not fit neatly into the rubric of intellectual
property protection as it is practiced in developed countries.6 9 That is
not to say that with some creative thinking developing countries
66. Nwabueze, supra note 23, at 389 (citing WORLD HEALTH ORG., GENOMICS AND
WORLD HEALTH: REPORT OF THE ADVISORY COMMITTEE ON HEALTH RESEARCH
(Nov. 25, 2003) available at http://www.who.int/gb/ebwha/pdf-files/EBI 11/eebl 1112.pdf).
67. See, e.g., Craig D. Jacoby & Charles Weiss, Recognizing Property Rights in
Traditional Biocultural Contribution, 16 STAN. ENVTL. L.J. 74 (1997).
68. Id.
69. Mike Holderness, Moral Rights and Authors' Rights: the Keys to the Information
Age, WARWICK-JILT, Feb. 27, 1998, http://www2.warwick.ac.uk/fac/soc/law/elj/jilt
/1998_1/holderness/ (last visited Nov. 23, 2008).
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cannot come up with a mechanism to leverage their traditional
knowledge while advancing their economic development, as discussed
more fully below.
B. Trademark Protection
A trademark has the potential to significantly impact the amount
of direct foreign investment; it "is a more powerful economic
development lever than trade.",71 In contrast to patented technology,
which often requires know-how in addition to any disclosure in a
patent application, trademarks primarily serve to identify goods in the
minds of consumers. It has been argued that by providing better
trademark protection, a company has "an incentive to invest in
making their marks more recognizable and easier to remember." 
71
This, in turn, can lead to a development of and investment in the local
economy, which will create jobs.
C. Licensing In/Licensing Out - the IBM Model
There was a time when IBM followed the traditional closed shop
thinking of many large multi-national companies: not interested if it
was "not invented here," and it certainly would not let people at their
intellectual property! Those days are long gone. IBM, a creature of
many reincarnations in its quest for corporate survival, has become a
lean, mean licensing machine. According to its web site, "[w]ith 13
consecutive years of U.S. patent leadership (having received more
U.S. patents than any other company in the world), IBM is expanding
its use of intellectual property to accelerate the adoption of open
standards and open source software through creative licensing and
stewardship programs. 
72
At first blush, the out-licensing of technology may seem
counterintuitive as a business practice. After all, hard earned
research and development dollars were spent working on a problem
and then additional funds were spent protecting it. How, then, does
letting another company use its technology advance IBM's corporate
agenda or the bottom line? IBM is no fool. It is currently offering
70. Daniel J. Gervais, Intellectual Property, Trade & Development: The State of Play,
74 FORDHAM L. REV. 505, 521 (2005-06).
71. Id.
72. IBM Intellectual Property and Licensing, http://www.ibm.com/ibm/licensing/ (last
visited Nov. 16, 2008).
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free licensing to universities to foster open standard development
and it is making licenses available to start-up companies. IBM
recognizes that by advancing technology it is increasing the number of
people and businesses that rely on its technology, leading to the
creation of a long-term, reliable revenue stream while maintaining a
good public image. There is a method to IBM's madness, much like
the method to Henry Ford's decision to pay his workers $5 a day so
that they, in turn, could afford to buy the cars they were
manufacturing.
There are many reasons why a company may ultimately make
the business decision to license its intellectual property rights.
Licensing affords the opportunity to essentially tap into the resources
of the licensee to penetrate markets that the company might not
otherwise be able to access .7 Licensing also affords broadening the
geographic reach of a company into new geographic markets and
potentially broadens product markets.76 Licensing into a non-
competing field can also provide easy access to revenue. In many
instances, the license is a tool for bartering with another company.
7
While out-licensing technology has been a good idea for IBM,
applying that practice to technology transferred to developing
countries presents cultural and technical hurdles. However, these are
likely hurdles that can be overcome with creative thinking and
planning.
VI. Is That All She Wrote?
Perhaps not. Although, there is evidence that suggests that "the
number of patents issued within a nation tends to rise with the size
and the level of economic development,",71 there are also examples of
countries that have used other techniques to change their position in
the world economy.
73. See, http://www-03.ibm.com/press/us/en/pressrelease/21846.wss (last visited Dec.
28, 2008).
74. Dawn Kawamoto, IBM Woos Start-Ups, CNET, Dec. 13, 2005, http://news.
cnet.com/2102-1011_3-5993221.html?tag=st.util.print.
75. JAY DRATLER, LICENSING OF INTELLECTUAL PROPERTY § 1.03 (Law Journal
Press 2002) (1994).
76. Id.
77. International Licensing of Intellectual Property: The Promise and the Peril, 1 J.
TECH. L. & POL'Y I (1996), available at http://grove.ufl.edu/-techlaw/voll/gikkas.html.
78. Padraig Dixon & Christine Greenhalgh, The Economics of Intellectual Property:
A Review to Identify Themes for Future Research, OXFORD INTELLECTUAL PROPERTY
RESEARCH CENTRE, Nov. 2002, http://www.oiprc.ox.ac.uk/EJWP0502.pdf.
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A. Ireland and Its Influence on El Salvador
Ireland, essentially a third world country in the 1980s with its
educated work force emigrating to find jobs, has, with the creation of
economic incentives and intellectual property rights, provided a
haven for companies to invest and has transformed itself from one of
the poorest countries in Europe to one of the richest. Over time,
every major medical device and pharmaceutical company in the
United States set up an operation in Ireland. As a result, the Irish
economy boomed, her native sons and daughters were wooed back
from abroad, and she took on the mantle of the Celtic Tiger during
the 1990s through 2001. Incentives for setting up in Ireland included
her membership in the European Union, her low corporate tax rate,
relatively low wages for skilled workers, and a highly educated
English-speaking work force. Ireland's progress may be a result of
many things, but at a minimum she illustrates the ability of a country
through good policy and external investment to turn itself around in a
relatively short time period.
Seeking to follow Ireland's success, El Salvador has adopted the
Irish model of developing workforce skills as opposed to focusing on
increasing domestic research funding. El Salvador's economy is a
United States dollar-based economy. El Salvador is in the process of
revitalizing her economy, looking toward Ireland's example and
leveraging her geographic proximity to the United States. In a recent
speech, Vice President Ana Escobar "outlined four pillars for
national education reform-increasing the number of years children
attend schools, strengthening math and science curricula, moving
towards bilingualism and providing students with access to technology
before they graduate high school."'") If all goes according to plan, El
Salvador will follow in Ireland's footsteps to become a Central
American Cinderella story within the next 10 years.
B. Bioprospecting, Done Right
As alluded to above, many developing countries have a wealth of
traditional knowledge or biological diversity that itself could provide
79. See Benjamin Powell, Markets Created a Pot of Gold in Ireland, CATO INSTITUTE,
Apr. 15, 2003, http://www.cato.org/pub-display.php?pub-id=3070.
80. Christian Martell, Vice President of El Salvador Speaks on Fighting Poverty, THE
BROWN DAILY HERALD, Apr. 11, 2007, http://media.www.browndailyheraid.com
/media/storage/paper472/news/2007/04/11/CampusNews/Vice-President.Of.El.
Salvador.Speaks.On.Fighting.Poverty-2834470.shtml.
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incentive for transfer of technology. Not surprisingly, there is a
wealth of criticism over the extent to which these riches are protected.
It has been argued that
knowledge and natural resources cultivated by indigenous
peoples over generations serve as free or low-cost inputs into
the proprietary industrial knowledge production process.
This... enables multinational corporations to claim protection,
such as patents, on 'purified' natural substances, by using
expensive technology usually not available to developing
states."'
Unchecked, the conversion of information and resources by
developed countries has the potential to create a new form of
colonization by developing countries.8
With all the hand-waving over biopiracy and the activities of
large companies from developed countries stealing the traditional
knowledge of local inhabitants from developing countries, the point
that local governments should have the ability to control what occurs
within their borders is often ignored. "Local governments, not
foreign bioprospectors, hold primary responsibility for environmental
damage attributable to the collection of biological specimens."'" So,
too, local governments have the power to control the manner in
which materials are taken and in which their populace is
compensated. Costa Rica leverages its natural resources and has
developed processes for ensuring sustainability. Even if local
governments are not willing to take control, developed countries can,
and should, provide incentives for developing countries to exercise
their sovereign rights.
VII. Conclusion
On balance, it would seem that intellectual property rights have a
positive impact on the economic development of a country. Even
81. Bradford S. Simon, Intellectual Property and Traditional Knowledge: A
Psychological Approach to Conflicting Claims of Creativity in International Law, 20
BERKELEY TECH. L.J. 1613, 1618 (2005).
82. VANDANA SHIVA, PROTECT OR PLUNDER?: UNDERSTANDING INTELLECTUAL
PROPERTY RIGHTS 49 (2001).
83. Jim Chen, There's No Such Thing as Biopiracy . . .and It's a Good Thing, 37
MCGEORGE L.REV. 1, 13 (2006).
84. See, National Biodiversity Institute, Costa Rica, http://www.inbio.ac.cr
/en/default.html.
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Dessemontet acknowledged in his speech that "there is a strong
correlation between the rate of patents sought by enterprise and the
general level of economic developments." ' 5 However, it would be
shear arrogance to presume that a one-size-fits-all approach toward
intellectual property protection will and should work for developing
countries. As noted by Sir Hugh Laddie,
[f]or too long intellectual property rights have been regarded as
food for the rich countries and poison for poor countries...
Poor countries may find them useful provided they are
accommodated to suit local palates. The ... appropriate diet
for each developing country needs to be decided on the basis of
what is best for its development, and that the international
community and governments in all countries should take
decisions with that in mind."<
In our fast paced world driven by immediate gratification, it is
convenient to try to find a magic bullet, the one thing that presents an
obstacle to achieving an objective. Reality is much more difficult. As
a practical matter, intellectual property rights present hurdles for
technology transfer to developing countries. However, there are
other forces in the mix as well. That is not to say that these forces
cannot be overcome with thought and creativity and, as suggested by
Sir Laddie, by accommodating the rights to fit the local palates.
85. Franqois Dessemontet, Professor, Schools of Law of Lausanne and Fribourg,
address at the WIPO Geneva Conference (Nov. 17, 2003), available at http://www.
wipo.int/documents/en/meetings/2003/wipo-wto/presentations/doc/dessemontet. doc.
86. Hugh Laddie, Commission on Intellectual Property Rights Foreword,
http://www.iprcommission.org/papers/pdfs/final-report/CIPRfullfinal.pdf (last visited Dec.
21,2008).
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